These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1030425)

  • 21. [The combined measles-yellow fever vaccination in African infants aged 6 to 10 months].
    Mouchon D; Pignon D; Vicens R; Tu-Ha-Thanh ; Tekaia F; Teulières L; Garrigue G
    Bull Soc Pathol Exot; 1990; 83(4):537-51. PubMed ID: 2286007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of the methods of cryopreservation and lyophilization of vaccine against duckling hepatitis virus from "K-IP" strain].
    Stegniĭ MIu
    Mikrobiol Z; 2006; 68(4):78-84. PubMed ID: 17100332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of Brucella abortus strain RB51 lyophilized and as liquid vaccine under different storage conditions.
    Capsel RL; Olsen SC; Cheville NF; Thoen CO
    Biologicals; 2000 Dec; 28(4):209-15. PubMed ID: 11237356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermostability and efficacy in the field of a new, stabilized yellow fever virus vaccine.
    Georges AJ; Tible F; Meunier DM; Gonzalez JP; Beraud AM; Sissoko-Dybdahl NR; Abdul-Wahid S; Fritzell B; Girard M; Georges-Courbot MC
    Vaccine; 1985 Sep; 3(3):313-5. PubMed ID: 4060841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle.
    Jepson CD; March JB
    Vaccine; 2004 Jun; 22(19):2413-9. PubMed ID: 15193403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on rinderpest culture vaccine. 3. Stability of the lyophilised product.
    Plowright W; Rampton CS; Taylor WP; Herniman KA
    Res Vet Sci; 1970 Jan; 11(1):71-81. PubMed ID: 5533977
    [No Abstract]   [Full Text] [Related]  

  • 27. Strategies for improved stability of Peste des Petits Ruminants Vaccine.
    Silva AC; Carrondo MJ; Alves PM
    Vaccine; 2011 Jul; 29(31):4983-91. PubMed ID: 21570436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of time-expired yellow fever vaccine: public health response and results of a serological investigation.
    Allen KW; Nguyen-Van-Tam JS; Howells J
    Commun Dis Public Health; 1999 Jun; 2(2):141-2. PubMed ID: 10402751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stabilization of rinderpest vaccine by modification of the lyophilization process.
    House JA; Mariner JC
    Dev Biol Stand; 1996; 87():235-44. PubMed ID: 8854023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing the stability of live oral attenuated bacterial vaccines.
    Cryz SJ; Pasteris O; Varallyay SJ; Fürer E
    Dev Biol Stand; 1996; 87():277-81. PubMed ID: 8854028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting the stability of viral vaccines.
    Peetermans J
    Dev Biol Stand; 1996; 87():97-101. PubMed ID: 8854006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation of a live bacterial vaccine for stable room temperature storage results in loss of acid, bile and bile salt resistance.
    Edwards AD; Slater NK
    Vaccine; 2008 Oct; 26(45):5675-8. PubMed ID: 18761389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stabilization of a freeze-dried recombinant streptokinase formulation without serum albumin.
    López M; González LR; Reyes N; Sotolongo J; Pujol V
    J Clin Pharm Ther; 2004 Aug; 29(4):367-73. PubMed ID: 15271104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is there an alternative to the amaril 17D vaccine?].
    Saluzzo JF
    Bull Soc Pathol Exot; 1999 Dec; 92(5 Pt 2):436. PubMed ID: 11000959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stability of a new thermostable 17D yellow fever vaccine].
    Durand JP; Kollo B; Merlin M; Le Hesran JY; Josse R; Garrigue GP
    J Biol Stand; 1988 Jan; 16(1):1-7. PubMed ID: 3350820
    [No Abstract]   [Full Text] [Related]  

  • 37. [Freeze drying methods for smallpox cell culture vaccines].
    Herrero E; Meggers R
    Zentralbl Bakteriol Orig; 1968; 209(1):1-9. PubMed ID: 5746321
    [No Abstract]   [Full Text] [Related]  

  • 38. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Field trial of combined yellow fever and measles vaccines among children in Nigeria.
    Adu FD; Omotade OO; Oyedele OI; Ikusika O; Odemuyiwa SO; Onoja AL
    East Afr Med J; 1996 Sep; 73(9):579-82. PubMed ID: 8991237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study on the stability of 17D-204 yellow fever vaccine before and after stabilization.
    Sood DK; Aggarwal RK; Sharma SB; Sokhey J; Singh H
    Vaccine; 1993; 11(11):1124-8. PubMed ID: 8249431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.